JPH02288818A - Cosmetic containing treated material of shikonins - Google Patents
Cosmetic containing treated material of shikoninsInfo
- Publication number
- JPH02288818A JPH02288818A JP1661590A JP1661590A JPH02288818A JP H02288818 A JPH02288818 A JP H02288818A JP 1661590 A JP1661590 A JP 1661590A JP 1661590 A JP1661590 A JP 1661590A JP H02288818 A JPH02288818 A JP H02288818A
- Authority
- JP
- Japan
- Prior art keywords
- shikonins
- shikonin
- protein
- peptide
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001071917 Lithospermum Species 0.000 title claims abstract description 32
- 239000002537 cosmetic Substances 0.000 title claims abstract description 23
- 239000000463 material Substances 0.000 title abstract description 4
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 18
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 13
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 229910052742 iron Inorganic materials 0.000 claims abstract description 6
- 239000011777 magnesium Substances 0.000 claims abstract description 6
- 239000011701 zinc Substances 0.000 claims abstract description 6
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000010949 copper Substances 0.000 claims abstract description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910052802 copper Inorganic materials 0.000 claims abstract description 4
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 4
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 4
- 239000003125 aqueous solvent Substances 0.000 claims 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 abstract description 26
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 abstract description 20
- 239000000049 pigment Substances 0.000 abstract description 11
- 239000003086 colorant Substances 0.000 abstract description 10
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 9
- 230000007815 allergy Effects 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 7
- 230000000172 allergic effect Effects 0.000 abstract description 6
- 208000026935 allergic disease Diseases 0.000 abstract description 3
- 239000003021 water soluble solvent Substances 0.000 abstract 2
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 239000002244 precipitate Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000000144 pharmacologic effect Effects 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 108010022355 Fibroins Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108010013296 Sericins Proteins 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- -1 Gasein Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000172533 Viola sororia Species 0.000 description 1
- FHISHQWBZFWXSQ-UHFFFAOYSA-K [Al+3].[Cl-].[Cl-].[Cl-].OC Chemical compound [Al+3].[Cl-].[Cl-].[Cl-].OC FHISHQWBZFWXSQ-UHFFFAOYSA-K 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011867 re-evaluation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000001040 synthetic pigment Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
(イ)発明の目的
本発明はシコニン又は、その誘導体(シコニン類)を皮
膚化粧料中に、着色料又は顔料として用いるに当り、シ
コニン類の有する皮膚に対する接触アレルギー作用の発
現を除去させた、安全性の高い化粧料に関する。Detailed Description of the Invention (a) Purpose of the Invention The present invention aims to reduce the contact allergic effect of shikonins on the skin when they are used as colorants or pigments in skin cosmetics. This invention relates to highly safe cosmetics that eliminate the expression of
(産業上の利用分野)
本発明によるシコニン又は、その誘導体は、直接に皮膚
に付着しても、接触アレルギー作用を示すことがなく、
従って、化粧料全般の着色料又は顔料として繁用出来る
。(Industrial Application Field) The shikonin or its derivative according to the present invention does not exhibit contact allergic effects even if it is directly attached to the skin.
Therefore, it can be frequently used as a coloring agent or pigment in cosmetics in general.
又、本発明によるシコニン又は、シコニン誘導体の接触
性アレルギーを除去するために採用した手段は、プロテ
ィン又はペプチド類と共に、特定の金属イオンを用いて
、その混合撹拌による処理生成物又は組成物を用いるこ
とにあるも、この手段を用いれば、他の各種の合成色素
又は着色料、あるいは、その他の化粧料配合原料として
用いられる薬剤で、接触性アレルギーを誘発することが
知られている様な物質に対して、化粧料製剤化における
、その防御の為の有効な前処理手段として利用できる。In addition, the means adopted for eliminating contact allergy caused by shikonin or shikonin derivatives according to the present invention is to use a treatment product or composition by mixing and stirring a specific metal ion together with proteins or peptides. In particular, if this method is used, various other synthetic pigments or colorants, or other drugs used as raw materials for cosmetic formulations, which are known to induce contact allergies, can be removed. It can be used as an effective pretreatment means to protect against this in the formulation of cosmetics.
「第1表」主なシコニン誘導体(シコニン類〕(従来の
技術)
シコニン又はシコニン誘導体は、ムラサキ草の根茎中に
含まれる、色素成分の一つとして知られ、薬理的作用と
しては、消炎、鎮静、抗菌作用、肉芽形成促進作用が知
られている。"Table 1" Main shikonin derivatives (shikonins) (prior art) Shikonin or shikonin derivatives are known as one of the pigment components contained in the roots of purple grass, and have pharmacological effects such as anti-inflammatory and sedative effects. It is known for its antibacterial and granulation-promoting effects.
一方、ムラサキ草の根茎は、これを用いて古くから、衣
類繊維の染料として用いられてきた歴史があり、更に、
その色素を正体とJ−る抽出エギスは、化粧料に配合さ
れている。On the other hand, the rhizomes of purple grass have a long history of being used as dyes for clothing fibers, and furthermore,
Extracted Egis, whose true color is the pigment, is blended into cosmetics.
シコンエキスを化粧料に用いるに当っては、その目的が
大別して二つに区別され、その一つが、前述したシコニ
ンなどの有する薬理的作用の期待であり、更にもう一つ
は、着色料又は顔料としての利用であった。When using Shikonin extract in cosmetics, its purpose can be roughly divided into two types. One of them is the expectation of the pharmacological action of Shikonin, etc. mentioned above, and the other is to use it as a coloring agent or pigment. It was used as a.
(公知刊行物)
シコニンやシコニン誘導体、又はムラサキの根茎(以下
、漢方名称に準拠し、これをシコンと呼ぶ)に関する公
知刊行物としては、例えば、日本国特許庁発行による次
の公報がある。(Known Publications) Known publications regarding shikonin, shikonin derivatives, or rhizomes of purple violet (hereinafter referred to as shikon in accordance with the Chinese medicine name) include, for example, the following publication published by the Japan Patent Office.
(1)公開特許公報 昭50−49409 (*)(2
)公開特許公報 昭52−94432 (*)(3)公
開特許公報 昭59−10507 (*)(4)公開特
許公報 昭6O−58909(5)公開特許公報 昭6
O−58910(6)公開特許公報 昭60−5891
1(7)公開特許公報 昭58−28279(8)公開
特許公報 昭58−28278上記刊行物中、(1〜3
)は、本発明者らによるものである。(1) Published Patent Publication 1984-49409 (*)(2
) Published Patent Publication 1987-94432 (*) (3) Published Patent Publication 1987-10507 (*) (4) Published Patent Publication 1982-58909 (5) Published Patent Publication 1982
O-58910 (6) Published Patent Publication 1986-5891
1 (7) Published Patent Publication 1982-28279 (8) Published Patent Publication 1982-28278 Among the above publications, (1 to 3)
) is by the present inventors.
化粧料においては、従来、王として着色料又は顔料とし
て用いるにおいては、シコン抽出エギスのリキッド化さ
れたもので、例えば、前記公開特許公報(1)で示され
る製品(シコニソクスリキッド、−丸フデルコス製)で
は、02〜05%が適量として用いられ、この配合量で
は、薬理的作用は緩和であり、化粧料への着色料として
用いるには、何ら問題点はなかった。Conventionally, in cosmetics, when used as a coloring agent or pigment, a liquid version of Shikonisokusu extract has been used, for example, the product shown in the above-mentioned published patent publication (1) (Shikonisox liquid, - round). (manufactured by Fudelcos), 02 to 05% is used as an appropriate amount, and at this amount, the pharmacological action is mild, and there are no problems when used as a coloring agent for cosmetics.
(発明が解決しようとする問題点)
シコニン類は、現在、前記刊行物(7〜8)に示すごと
く、シコンの組織培養法による生産が可能となり、これ
をもとに大量生産(抽出単離)することが可能となった
。(Problems to be Solved by the Invention) Shikonins can now be produced by the tissue culture method of Shikonins, as shown in the publications (7-8), and based on this, they can be mass-produced (extraction and isolation). ) became possible.
筆離されたシコニン又は、シコニン誘導体は、従来のシ
コンエキスとG」異なり、薬理的活性は強力であり、こ
れを化粧料に着色料又は顔料として配合するとなると、
シコニンの有づ−る薬理的作用と共に、相反する副作用
として、皮膚に刻する接触アレルギー作用を誘発するこ
とに対する配慮が必要であるが、この点は、従来あまり
知られていなかった。The separated shikonin or shikonin derivative has strong pharmacological activity, unlike conventional shikonin extract, and when it is incorporated into cosmetics as a coloring agent or pigment,
In addition to the pharmacological action of shikonin, it is necessary to take into consideration the fact that it induces a contact allergic action on the skin, which is a contradictory side effect, but this point has not been well known in the past.
そして、シコニンの何する着色料又は顔料として、化粧
料に用いるに当っては、これまで、接触アレルギーの誘
発を防御1−る様な手段は、全(開示されないでいた。Until now, no means have been disclosed to prevent the induction of contact allergies when using shikonin as a colorant or pigment in cosmetics.
本発明音らは、薬理的作用とその安全性に関する再評価
試験を追試しながら、この点を解決する為の研究を開始
し、本発明を完成するに至った。The inventors of the present invention began research to solve this problem while conducting re-evaluation tests regarding pharmacological effects and their safety, and were able to complete the present invention.
(ロ)発明の構成
本発明は、シコニン類を(シコニン又は、シコニン誘導
体に対し)、特定した金属イオンと、プロティン、又は
ペプチド、又は、プロティンとペプチドとの混合物の水
溶性温媒溶液中で混合処理することによって得られる、
シコニン類の処理物を、化粧料に含有して用いるもので
ある。(B) Structure of the Invention The present invention provides a method for preparing shikonins (for shikonin or shikonin derivatives) in an aqueous hot medium solution of a specified metal ion and a protein, a peptide, or a mixture of a protein and a peptide. obtained by mixing,
A processed product of shikonins is used by containing it in cosmetics.
(問題点を解決するための手段)
「実施例1」
シコニン原末、又はシコニン誘導体(第1表に示すもの
)、又は、それらの混合物を、エタノール又はメタノー
ルと水との混合液中に溶解した液に、2%塩化アルミニ
ウムメタノール溶液、又は1%塩化第2鉄エタノール溶
液、又は、亜鉛(Zn゛)溶液、マグネシウム(M g
”)溶液、銅(Cu ”)溶液の、いずれか1種類の
金属イオン溶液に、更に、水溶性のプロティン、又は、
水溶性のペプチド、又は、水溶性のプロティンと水溶性
のペプチドの混合物であれば、特に限定する必要はない
が、例えば、植物性の小麦グルテン、大豆蛋白である豆
乳、動物性アルブミン、血清、ガセイン、ゼラチン、プ
ラセンターエキス、あるいは、プラセンター、コラーゲ
ン、エラスチン、ケラチン、フィブロイン、セリシンな
どの加水分解又は酵素分解によって得られた、低分子化
された水溶性のプロティン又はペプチドの水溶液を混合
し撹拌する。(Means for solving the problem) "Example 1" Shikonin bulk powder, shikonin derivatives (shown in Table 1), or a mixture thereof is dissolved in ethanol or a mixture of methanol and water. 2% aluminum chloride methanol solution, 1% ferric chloride ethanol solution, zinc (Zn゛) solution, magnesium (Mg
``) solution, copper (Cu '') solution, any one type of metal ion solution, and further water-soluble protein, or
There is no particular limitation as long as it is a water-soluble peptide or a mixture of a water-soluble protein and a water-soluble peptide, but examples include vegetable wheat gluten, soy milk that is soy protein, animal albumin, serum, Gasein, gelatin, placenta extract, or an aqueous solution of low-molecular water-soluble proteins or peptides obtained by hydrolysis or enzymatic decomposition of placenta, collagen, elastin, keratin, fibroin, sericin, etc. Stir.
次に、0.IN水酸化ナトリウム溶液を加え、前記の混
合撹拌溶液のpHを7〜8に調整することによって、急
速な沈殿物が形成される。そこでこの沈殿物を取り、良
く水洗してから各種の公知な化粧料中に配合する。又、
沈殿物は、良(水洗し乾燥して粉末状となして保存し、
必要に応じて化粧料中に配合して用いても良く、又、沈
殿物を良く水洗した後、0.1〜0.2N水酸化ナトリ
ウム溶液に溶解させた後、更に、2N塩酸溶液を用いて
中和して、PEG(ポリエチレングリコル)、プロピレ
ングリコール、ブチレングリコールなどのポリオール系
溶剤や、水やエタノール又は水やエタノールと共に、ポ
リオール系溶剤中に混合させた後、化粧料に配合して用
いても良い「実施例2」
水に不溶性のプロティンを主体となす粉体物、例えば、
植物性の大豆由来の水に不溶性のプロティン、シルクパ
ウダー、フィブロイン、セリシンコラーゲン、エラスチ
ン、ケラチンなどの動物由来の蛋白質を、5%酢酸アル
ミニウム水溶液、又は、鉄(Fe’″″″″)、亜鉛(
Zn〜)、マグネシウム(Mg”)、銅(Cu−)の金
属イオン溶液の1種類中に加えて撹拌し、分散させてか
ら、夜装置し、濾過、水洗した後、沈殿物を分取する。Next, 0. A rapid precipitate is formed by adding IN sodium hydroxide solution and adjusting the pH of the mixed stirring solution to 7-8. Therefore, this precipitate is removed, thoroughly washed with water, and then incorporated into various known cosmetics. or,
The precipitate is fine (washed with water, dried and stored as a powder,
If necessary, it may be used by blending it into cosmetics, and after thoroughly washing the precipitate with water and dissolving it in a 0.1 to 0.2N sodium hydroxide solution, further using a 2N hydrochloric acid solution. It is neutralized and mixed in a polyol solvent such as PEG (polyethylene glycol), propylene glycol, butylene glycol, water, ethanol, or water and ethanol, and then blended into cosmetics. "Example 2" which may be used Powder material mainly composed of water-insoluble proteins, e.g.
Animal-derived proteins such as water-insoluble protein derived from vegetable soybeans, silk powder, fibroin, sericin collagen, elastin, and keratin are mixed with a 5% aluminum acetate aqueous solution, iron (Fe'''''''), and zinc. (
Add to one type of metal ion solution of Zn~), magnesium (Mg"), and copper (Cu-), stir and disperse, then set aside overnight, filter, wash with water, and collect the precipitate. .
次に、シコニン又は、その誘導体(第1表に示す)、又
は、それらの混合物を、エタノール又はメタノールと水
の混合液中に加えて溶解させた液中に、先に得た沈殿物
を加え、60〜70℃の温浴中で、時々撹拌しながら、
約90分間の加温を行う。加温終了後、静置して、沈殿
物を分取し、脱水、水洗後、エタノール中に浸漬させ、
沈殿物を回収し、風乾後、80±5℃で減圧乾燥させて
粉末となす。この粉末を、任意の化粧料に配合する。Next, the precipitate obtained earlier was added to a solution in which shikonin, its derivatives (shown in Table 1), or a mixture thereof were dissolved in ethanol or a mixture of methanol and water. , in a hot bath at 60 to 70°C, with occasional stirring,
Heating is performed for about 90 minutes. After heating, let it stand, separate the precipitate, dehydrate it, wash it with water, and immerse it in ethanol.
The precipitate is collected, air-dried, and then dried under reduced pressure at 80±5°C to form a powder. This powder is blended into any cosmetic.
(ハ)発明の効果
前項の実施例1又は2で処理されたシコニン又はその誘
導体、あるいは、それらの混合物は、赤色又は、赤紫色
又は青紫色を呈し、皮膚に対する接触性アレルギー作用
を示さず、化粧料への若色料又は顔料として用いるのに
最適である。(c) Effects of the invention Shikonin or its derivatives treated in Example 1 or 2 of the preceding section, or a mixture thereof exhibits a red, reddish-purple, or bluish-purple color and does not exhibit a contact allergic effect on the skin; Ideal for use as a young colorant or pigment in cosmetics.
本発明による効果の判定は、マキシミゼーション法(文
献所在−新しい毒性試験と安全性の評価ソフトサイエン
ス社刊)に準拠し、併せて高瀬の方法(文献所在:フレ
グランスジャーナルN。The effectiveness of the present invention is determined based on the Maximization Method (Reference: New Toxicity Test and Safety Evaluation, published by Soft Science), as well as Takase's method (Reference: Fragrance Journal N).
14 フレグランスジャーナル社刊 1975年)をも
とに、モルモットを被験動物となし、感作方法は、皮肉
注射により、あらかじめシコニンを用いて、頚部に投与
した後、実施例1〜2で得られた処理後の沈殿物を検体
とし、これを親木軟膏中に配合し、塗布する方法で実施
した。又、塗布群は一群5匹により実施した。14 Fragrance Journal Co., Ltd., 1975), a guinea pig was used as the test animal, and the sensitization method was to use shikonin and administer it to the cervix by sarcastic injection. The precipitate after treatment was used as a specimen, and the test was carried out by blending this into a parent wood ointment and applying it. In addition, the application group was conducted with 5 animals per group.
次表(第2表)は、実施例1又は2によって、シコニン
を処理した沈殿物の成績結果を示したものである。第2
表に示すごとく、皮膚接触アレルギー作用は認められな
い様になる。The following table (Table 2) shows the results of the precipitates treated with shikonin according to Example 1 or 2. Second
As shown in the table, no skin contact allergic effects were observed.
この処理に対する効果について、シコニンの構造上から
一つの考察を加えてみると、その薬理的作用を有する活
性基は、次に示すごとくのシコニンの構造式から見ると
、−OHや=Oにあり、この−OHや二〇が、皮膚接触
アレルギーの発現の一つの引き金になって、皮膚を刺激
していたものと予想される。つまり、皮膚を構成するプ
ロティンに対して、−OHや=0が働きかけやすい(結
合しやすい)状態にあったことである。Considering the effect on this treatment from the structural perspective of shikonin, the active group that has pharmacological action is found in -OH and =O from the structural formula of shikonin as shown below. This -OH and 20 are expected to be one of the triggers for the development of skin contact allergies, irritating the skin. In other words, -OH and =0 were in a state where it was easy to act on (easily bond to) the proteins that make up the skin.
そこで、実施例1や2では、あらかじめ生体皮膚構成プ
ロティンに代替して、各種のプロティンやペプチドを用
いて反応させてしまうことによって、目的とする直接に
皮膚に塗布しても、接触アレルギーが発現されない様に
なったと推定している。Therefore, in Examples 1 and 2, by reacting with various proteins and peptides in place of biological skin constituent proteins in advance, contact allergies will not occur even if applied directly to the skin. It is estimated that this is no longer the case.
又、実施例1や2では、特定した金属イオン溶液として
、鉄やアルミニウムなどを使用したが、これを用いない
でも、一応、目的となす接触アレルギー作用は示さない
様になる。しかし、化粧料へ添加して、加温処理などが
加わる様なとき、例えば、乳化やクリームなどの場合、
又は大量に配合した場合には、時々、そのクリームや乳
液を用いて試験を行うと、皮膚接触アレルギーを示すこ
とがある。しかし、実施例1や2のごとく、特定された
金属イオンを用いたときでは、それが認められないこと
である。Further, in Examples 1 and 2, iron, aluminum, or the like was used as the specified metal ion solution, but even if iron or aluminum is not used, the intended contact allergy effect will not be exhibited. However, when added to cosmetics and subjected to heating treatment, such as emulsification or cream,
Or when used in large quantities, tests using the cream or emulsion can sometimes show skin contact allergies. However, when specific metal ions were used as in Examples 1 and 2, this was not observed.
この点に関して、更に、考察を加えてみると、おそら(
ば、−〇 Hや二〇に対して、鉄やアルミニウムなどは
、他のプロティンやペプチドの有ず1す
るヒスチジン基と、有効的な結合状態を持って、活性基
である一OHや=0の不活化に働きかけているものと推
定された。If we consider this point further, perhaps (
For example, in contrast to −〇 H and 20, iron and aluminum have an effective bonding state with the histidine group present in other proteins and peptides, and form active groups such as 1OH and =0. It is presumed that the enzyme acts on the inactivation of .
尚、本発明による処理方法は、他のキノン系の色素類の
皮膚接触アレルギーを抑制する手段としても利用できる
ことがわかった。It has been found that the treatment method according to the present invention can also be used as a means for suppressing skin contact allergies to other quinone pigments.
Claims (1)
マグネシウム、亜鉛、銅の内、その1種類の溶液と、プ
ロテイン又はペプチド、又はプロテインとペプチドとの
混合物の水溶性溶媒溶液中で、混合処理を行うことによ
って得られる、シコニン類の処理物を含有することを特
徴とする化粧料。(1) Shikonins contain aluminum, iron, and metal ions as metal ions.
Contains a processed product of shikonins obtained by mixing a solution of one of magnesium, zinc, and copper with a protein or peptide, or a mixture of protein and peptide in an aqueous solvent solution. A cosmetic product characterized by:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1661590A JPH02288818A (en) | 1990-01-25 | 1990-01-25 | Cosmetic containing treated material of shikonins |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1661590A JPH02288818A (en) | 1990-01-25 | 1990-01-25 | Cosmetic containing treated material of shikonins |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13255185A Division JPH0244865B2 (en) | 1985-06-17 | 1985-06-17 | SHIKONINRUINOSHORIHO |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02288818A true JPH02288818A (en) | 1990-11-28 |
Family
ID=11921236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1661590A Pending JPH02288818A (en) | 1990-01-25 | 1990-01-25 | Cosmetic containing treated material of shikonins |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02288818A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5294432A (en) * | 1976-01-31 | 1977-08-09 | Ichimaru Boeki | Production method of lithosperme radix for cosmetics |
JPS5910507A (en) * | 1982-07-09 | 1984-01-20 | Ichimaru Fuarukosu Kk | Cosmetic blended with pigmented powder of dyestuff extracted from lithospermum root |
JPS6058909A (en) * | 1983-09-12 | 1985-04-05 | Shiseido Co Ltd | Composition containing shikonin and/or its derivative |
-
1990
- 1990-01-25 JP JP1661590A patent/JPH02288818A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5294432A (en) * | 1976-01-31 | 1977-08-09 | Ichimaru Boeki | Production method of lithosperme radix for cosmetics |
JPS5910507A (en) * | 1982-07-09 | 1984-01-20 | Ichimaru Fuarukosu Kk | Cosmetic blended with pigmented powder of dyestuff extracted from lithospermum root |
JPS6058909A (en) * | 1983-09-12 | 1985-04-05 | Shiseido Co Ltd | Composition containing shikonin and/or its derivative |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE19860754B4 (en) | Cosmetic preparation | |
KR101363383B1 (en) | Hair dye, dyeing hair product combination and its use method | |
WO2004000257A2 (en) | Highly affine cosmetic agent | |
EP0056595A1 (en) | Hair treating composition and process for improving the condition of the hair | |
JP3480952B2 (en) | External preparation for skin | |
JPH0692821A (en) | Cosmetic containing eucommia ulmoides leaf extract | |
US20180369113A1 (en) | Personal care formulations comprising carmin protein | |
JPH03220115A (en) | Hair dyeing cosmetic | |
KR100569788B1 (en) | Composition for hairdye comprising mulberry, mulberry leaves or mori radicis cortex | |
JP5215603B2 (en) | Hair coat for dogs and cats as pet animals | |
JPH02288818A (en) | Cosmetic containing treated material of shikonins | |
DE2723908A1 (en) | PHARMACEUTICAL AND COSMETIC PREPARATIONS ON THE BASIS OF ELASTIN | |
JPH04187625A (en) | Hair-dyeing agent containing silver halide | |
JPH0244865B2 (en) | SHIKONINRUINOSHORIHO | |
JPH06128145A (en) | External agent for skin | |
CN110613678B (en) | Skin conditioner and essence for removing red blood streak and preparation method | |
JPH0940530A (en) | Hair cosmetic | |
JPS5910507A (en) | Cosmetic blended with pigmented powder of dyestuff extracted from lithospermum root | |
JPH03255014A (en) | Cosmetic | |
JPH049320A (en) | Whitening cosmetic | |
JPH05139938A (en) | Hair producing and growing agent | |
JPH0390012A (en) | Cosmetic | |
JP2003261429A (en) | Hair-dyeing agent, method for dyeing hair by using the same and hair washing method | |
JPH10101541A (en) | Cosmetic composition bringing about beautifying effect by removal of liver spots, darkening, and wrinkles from skin | |
JPH02142712A (en) | Cosmetic containing alkylation modified material of hydrolyzed product of protein derived from animal or plant |